Teresa Gagliano

About Teresa Gagliano

Teresa Gagliano, With an exceptional h-index of 16 and a recent h-index of 12 (since 2020), a distinguished researcher at Università degli Studi di Udine, specializes in the field of Biomedical Science.

His recent articles reflect a diverse array of research interests and contributions to the field:

Exploring Emerging Therapeutic Targets and Opportunities in Neuroendocrine Tumors: Updates on Receptor Tyrosine Kinases

Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids

Kinome‐Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma

Decoding the Tumour Microenvironment: Molecular Players, Pathways, and Therapeutic Targets in Cancer Treatment

Gender pressure in cancer: susceptibility, progression and treatment of the neoplastic disease

Estrogen receptor status heterogeneity in breast cancer tumor: role in response to endocrine treatment

Kinome-wide synthetic lethal screen identifies PANK4 as modulator of resistance in glioblastoma

HDACs and the epigenetic plasticity of cancer cells: Target the complexity

Teresa Gagliano Information

University

Position

___

Citations(all)

711

Citations(since 2020)

443

Cited By

425

hIndex(all)

16

hIndex(since 2020)

12

i10Index(all)

23

i10Index(since 2020)

14

Email

University Profile Page

Google Scholar

Teresa Gagliano Skills & Research Interests

Biomedical Science

Top articles of Teresa Gagliano

Exploring Emerging Therapeutic Targets and Opportunities in Neuroendocrine Tumors: Updates on Receptor Tyrosine Kinases

2024/4/5

Teresa Gagliano
Teresa Gagliano

H-Index: 12

Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids

Biomedicine & Pharmacotherapy

2024/4/1

Kinome‐Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma

Advanced Science

2024/2/14

Decoding the Tumour Microenvironment: Molecular Players, Pathways, and Therapeutic Targets in Cancer Treatment

2024/1/31

Georgios Giamas
Georgios Giamas

H-Index: 22

Teresa Gagliano
Teresa Gagliano

H-Index: 12

Gender pressure in cancer: susceptibility, progression and treatment of the neoplastic disease

Frontiers in Endocrinology

2023/9/4

Teresa Gagliano
Teresa Gagliano

H-Index: 12

Estrogen receptor status heterogeneity in breast cancer tumor: role in response to endocrine treatment

Cancer Gene Therapy

2023/7

Georgios Giamas
Georgios Giamas

H-Index: 22

Teresa Gagliano
Teresa Gagliano

H-Index: 12

Kinome-wide synthetic lethal screen identifies PANK4 as modulator of resistance in glioblastoma

2023/3/27

HDACs and the epigenetic plasticity of cancer cells: Target the complexity

2022/10/1

Claudio Brancolini
Claudio Brancolini

H-Index: 23

Teresa Gagliano
Teresa Gagliano

H-Index: 12

Cancer gene therapy 2020: highlights from a challenging year

Cancer Gene Therapy

2022/1

Georgios Giamas
Georgios Giamas

H-Index: 22

Teresa Gagliano
Teresa Gagliano

H-Index: 12

LMTK3 inhibition affects microtubule stability

Molecular cancer

2021/12

The multifaceted role of lemur tyrosine kinase 3 in health and disease

2021/9/29

Teresa Gagliano
Teresa Gagliano

H-Index: 12

Georgios Giamas
Georgios Giamas

H-Index: 22

Targeting histone deacetylases for combination therapies in neuroendocrine tumors

2021/6

Teresa Gagliano
Teresa Gagliano

H-Index: 12

Claudio Brancolini
Claudio Brancolini

H-Index: 23

Epigenetic mechanisms beyond tumour–stroma crosstalk

2021/2/22

Teresa Gagliano
Teresa Gagliano

H-Index: 12

Claudio Brancolini
Claudio Brancolini

H-Index: 23

Quis custodiet ipsos custodes (who controls the controllers)? Two decades of studies on HDAC9

2021/1/27

The structure-function relationship of oncogenic LMTK3

Science Advances

2020/11/13

Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing

Oncogene

2020/9/24

PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression

The Journal of clinical investigation

2020/6/1

See List of Professors in Teresa Gagliano University(Università degli Studi di Udine)